DexCom's Q3 performance shows impressive organic growth rates and increased revenue guidance for 2023. The company's strategic focus on international markets and expanding customer bases indicates ...
The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users. Taylor Leamey wrote about all things wellness for CNET, specializing in ...
We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other ...
The "direct-to-watch" feature eliminates the need to keep your phone near for readings. Dexcom is looking into other smartwatches too, the company's COO says. Jessica was a writer on the Wellness team ...
Dexcom’s over-the-counter continuing glucose monitor (CGM) has been approved by the Food and Drug Administration (FDA), the company announced Tuesday afternoon. The CGM, dubbed Stelo, consists of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback